2020 Virtual ESMO Review


 

2020 ESMO Update on Advanced UC: Does the Addition of Avelumab 1L Maintenance to BSC in Advanced Disease Affect on Clinically Relevant PROs? Is There More PFS/OS Benefit Upon the Addition of Pembro to Chemo?

74 views
November 16, 2020
Comments 0
Login to view comments. Click here to Login